Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-12-19Clinical Trial Update: Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia [Phase 3]
Reviva Pharmaceuticals' Brilaroxazine (RP5063) is in a Phase 3 schizophrenia trial assessing safety and efficacy, currently recruiting.
-
EMA approval · 2024-12-18EMA Authorised: Zyprexa Velotab (olanzapine) — CHEPLAPHARM Registration GmbH
The EMA authorised Zyprexa Velotab, a generic olanzapine product, under CHEPLAPHARM Registration GmbH for schizophrenia and bipolar disorder…
-
CLINICAL_TRIALS trial_result · 2024-12-18Clinical Trial Update: Motivation Skills Training for Schizophrenia [NA]
Completed clinical trial evaluating Motivation Skills Training for schizophrenia and schizoaffective disorder; results have been posted.
-
CLINICAL_TRIALS research · 2024-12-17Clinical Trial Update: Neuromodulation for Schizophrenia [NA]
A clinical trial is recruiting to evaluate a neuromodulation therapy for schizophrenia, sponsored by Scion NeuroStim.
-
CLINICAL_TRIALS trial_result · 2024-12-17Clinical Trial Update: Impact of a Ketogenic Diet on Metabolic and Psychiatric Health in Patients With Bipolar or Schizophrenia Illness [NA]
A completed clinical trial assessed the effects of a ketogenic diet on metabolic and psychiatric health in adults with bipolar disorder or s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: Imaging Synapses With [11C] UCB-J in the Human Brain [Phase 1]
Phase 1 trial evaluating [11C] UCB-J as a brain imaging tracer for synapses in schizophrenia, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-12-16Clinical Trial Update: A Clinical Study to Evaluate the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia [Phase 3]
A Phase 3 long-term safety and tolerability study for an investigational schizophrenia drug sponsored by Otsuka has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia [Phase 3]
Phase 3 trial evaluating efficacy and safety of iloperidone compared with placebo and an active control in adults with acute schizophrenia; …
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: Personalized Dual-target RTMS for Patients with Refractory Schizophrenia [NA]
A clinical trial update announces completion of a study evaluating personalized dual-target repetitive transcranial magnetic stimulation (RT…
-
CLINICAL_TRIALS trial_result · 2024-12-12Clinical Trial Update: Developing Dual-channel Transcranial Alternating Current Stimulations Targeting Negative Symptoms in Schizophrenia [NA]
This clinical trial update notes the completion of a study evaluating dual-channel transcranial alternating current stimulation for negative…
-
CLINICAL_TRIALS research · 2024-12-12Clinical Trial Update: Development and Application of Precision Treatment Strategies for Common Mental Disorders [NA]
This clinical trial update from Peking University describes the development and application of precision treatment strategies for common men…
-
FDA approval · 2024-12-12FDA Approved: CLOZAPINE — Original Application (Aurobindo Pharma Limited)
The FDA approved the original application for CLOZAPINE by Aurobindo Pharma Limited, authorizing a generic Clozapine product.
-
CLINICAL_TRIALS research · 2024-12-12Clinical Trial Update: Mental Health During the Whole Life Cycle of Community Patients with Schizophrenia
This ClinicalTrials.gov entry notes a study on mental health across the life cycle in community patients with schizophrenia, sponsored by Sh…
-
FDA approval · 2024-12-11FDA Approved: REXULTI — Supplemental Application (Otsuka America Pharmaceutical, Inc.)
FDA approves a supplemental application for Rexulti (brexpiprazole) submitted by Otsuka America Pharmaceutical, Inc.
-
CLINICAL_TRIALS trial_result · 2024-12-10Clinical Trial Update: Randomized Double Blind Placebo Control Study in Patients with Schizophrenia [Phase 2]
Phase 2 randomized double-blind placebo-controlled trial in schizophrenia and related psychotic disorders has completed; sponsor: Pakistan I…
-
FDA approval · 2024-12-10FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Original Application (Fresenius Kabi USA, LLC)
The FDA approved an original application for chlorpromazine hydrochloride from Fresenius Kabi USA, LLC, making this generic antipsychotic av…
-
CLINICAL_TRIALS trial_result · 2024-12-09Clinical Trial Update: A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-3) [Phase 3]
The Phase 3 EMERGENT-3 trial evaluating KarXT in acutely psychotic hospitalized adults with schizophrenia has completed and results were pos…
-
CLINICAL_TRIALS withdrawal · 2024-12-09Clinical Trial Update: The Sub-Sero Study [Phase 2]
Phase 2 trial titled 'The Sub-Sero Study' sponsored by Bjorn H. Ebdrup has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-12-09Clinical Trial Update: Effect of Simulation on Emotional Expression and Perceived Family Burden of Caregivers [NA]
A completed clinical trial evaluating whether a simulation intervention changes emotional expression in caregivers and their perceived famil…
-
CLINICAL_TRIALS research · 2024-12-09Clinical Trial Update: Study of Intra- and Interpersonal Multimodal Synchronizations in a Social Interaction in Individuals with a Diagnosis of Schizophrenia. [NA]
This update notes a recruiting clinical study at University Hospital, Montpellier, investigating intra- and interpersonal multimodal synchro…
-
CLINICAL_TRIALS trial_result · 2024-12-09Clinical Trial Update: Neural Correlates of Social Touch and Interoceptive Perception As Potential Biomarker for Impaired Social Functioning
The study investigates neural correlates of social touch and interoceptive perception as potential biomarkers for impaired social functionin…
-
CLINICAL_TRIALS research · 2024-12-09Clinical Trial Update: Add-on MEmaNtine to Dopamine Modulation to Improve Negative Symptoms at First Psychosis [Phase 1]
Phase 1 clinical trial evaluating memantine as an add-on to dopamine modulation to improve negative symptoms in first-episode psychosis.
-
CLINICAL_TRIALS trial_result · 2024-12-06Clinical Trial Update: Context-Aware Mobile Intervention for Social Recovery in Serious Mental Illness [NA]
Clinical trial on a context-aware mobile intervention for social recovery in serious mental illness has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine [NA]
This ClinicalTrials.gov update shows a completed study on melatonin metabolism abnormalities in patients with schizophrenia or schizoaffecti…
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: Virtual Reality for Visual Perception on Schizophrenia [NA]
A completed clinical trial evaluating virtual reality-based visual perception interventions for schizophrenia.